Abstract
Schizophrenia affects persons of all races and ethnicities worldwide. Racial and ethnic disparities exist with respect to diagnosis, treatment, and outcome. Therefore, mental health clinicians need to educate themselves about how to maximize their accuracy of diagnosis to prevent misdiagnosis and tailor treatment to patients' unique cultural backgrounds, which can influence their perception of their illness and their response to therapies. A patient-centered approach can maximize treatment outcomes and improve quality of life.
Original language | English (US) |
---|---|
Pages (from-to) | 354-363 |
Number of pages | 10 |
Journal | Drug Benefit Trends |
Volume | 17 |
Issue number | 8 |
State | Published - Aug 2005 |
Keywords
- Antipsychotic agents
- Minority mental health care
- Pharmacologic therapy
- Psychotherapy
- Schizophrenia
ASJC Scopus subject areas
- Health Policy
- Pharmacology (medical)